OptimizeRx Corp — Director's Dealing 2024

Jan 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-01-09

Reporting Person: FEBBO WILLIAM J (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-09	Common Stock	M	9628	—	Acquired	481028	Direct
2024-01-09	Common Stock	F	2884	$13.25	Disposed	478144	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-09	Restricted Stock Units	$	M	9628	Disposed		Common Stock (9628)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

F3: On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.